Scisparc Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Scisparc Ltd and you would like to use your Sustainability aseessment, please contact us. Other corporations in the scoring peer group for Scisparc Ltd are shownin the table. Comprehensive ESG assessment of Scisparc Ltd are accessed by signing in.
Scisparc Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.
0.9
Low ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1725478325797)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1810 | XBiotech Inc | 1.1 | Low |
1826 | Mitsubishi Tanabe Pharma Corp | 1.0 | Low |
1827 | Scisparc Ltd | 0.9 | Low |
1827 | CannTrust Holdings Inc | 0.9 | Low |
1827 | Cannabis Poland SA | 0.9 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1725478325797)
Frequently Asked Questions
Does Scisparc Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Scisparc Ltd disclose current and historical energy intensity?
Does Scisparc Ltd report the average age of the workforce?
Does Scisparc Ltd reference operational or capital allocation in relation to climate change?
Does Scisparc Ltd disclose its ethnicity pay gap?
Does Scisparc Ltd disclose cybersecurity risks?
Does Scisparc Ltd offer flexible work?
Does Scisparc Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Scisparc Ltd disclose the number of employees in R&D functions?
Does Scisparc Ltd conduct supply chain audits?
Does Scisparc Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Scisparc Ltd conduct 360 degree staff reviews?
Does Scisparc Ltd disclose the individual responsible for D&I?
Does Scisparc Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Scisparc Ltd disclose current and / or historical scope 2 emissions?
Does Scisparc Ltd disclose water use targets?
Does Scisparc Ltd have careers partnerships with academic institutions?
Did Scisparc Ltd have a product recall in the last two years?
Does Scisparc Ltd disclose incidents of discrimination?
Does Scisparc Ltd allow for Work Councils/Collective Agreements to be formed?
Has Scisparc Ltd issued a profit warning in the past 24 months?
Does Scisparc Ltd disclose parental leave metrics?
Does Scisparc Ltd disclose climate scenario or pathway analysis?
Does Scisparc Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Scisparc Ltd disclose the pay ratio of women to men?
Does Scisparc Ltd support suppliers with sustainability related research and development?
Does Scisparc Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Scisparc Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Scisparc Ltd involved in embryonic stem cell research?
Does Scisparc Ltd disclose GHG and Air Emissions intensity?
Does Scisparc Ltd disclose its waste policy?
Does Scisparc Ltd report according to TCFD requirements?
Does Scisparc Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Scisparc Ltd disclose energy use targets?
Does Scisparc Ltd disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Scisparc Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Scisparc Ltd
These potential risks are based on the size, segment and geographies of the company.
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.